Status:
COMPLETED
A Midazolam Drug Interaction Study With PF-04171327
Lead Sponsor:
Pfizer
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate the effects of multiple doses of PF-04171327 on the blood levels (pharmacokinetics) of midazolam
Eligibility Criteria
Inclusion
- Healthy males and/or females (non-childbearing potential) volunteers.
- Cortisol level within normal reference range of the laboratory.
Exclusion
- History of intolerance or significant adverse effect with glucocorticoid (steroid) therapy.
- History or current positive results for HIV, Hepatitis B or C or active TB or currently undergoing treatment for TB.
- Known history of hypersensitivity, allergy severe drug reaction or unable to tolerate midazolam or other benzodiazepines.
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00987038
Start Date
September 1 2009
End Date
December 1 2009
Last Update
December 8 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511